Literature DB >> 6336975

Effect of allopurinol on the toxicity of high-dose 5-fluorouracil administered by intermittent bolus injection.

S B Howell, C E Pfeifle, W E Wung.   

Abstract

The effect of allopurinol pretreatment on the toxicity of 5-fluorouracil (5-FU) was examined in a clinical trial. Twenty-three patients were given bolus infusions of 5-FU every two weeks in doses that produced mild toxicity (0.8-1.9 g/m2). On alternate courses patients were pretreated with allopurinol either 300 mg two hours prior to and 10 hours after 5-FU, or 300 mg every 8 hours for 4 doses starting 24 hours before 5-FU. Seventeen and 20 pairs of courses were evaluable from the 2- and 24-hour pretreatment groups, respectively. Allopurinol did not produce a significant degree of protection against 5-FU-induced myelosuppression or mucositis on either dose schedule. Neurotoxicity manifesting as both cerebellar and encephalopathic signs and symptoms was the most important toxicity encountered and was dose-limiting for 5-FU on this schedule. Mean oxipurinol serum concentrations at the time of 5-FU administration were 24 microM and 104 microM for the 2- and 24-hour allopurinol pretreatment schedules respectively. Allopurinol increased the T 1/2 of 5-FU by a mean of 67% in three of the four patients studied. Pretreatment with allopurinol did not reduce the toxicity of 5-FU administered as an intravenous bolus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6336975     DOI: 10.1002/1097-0142(19830115)51:2<220::aid-cncr2820510209>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

Review 1.  Interventions for preventing oral mucositis for patients with cancer receiving treatment.

Authors:  Helen V Worthington; Jan E Clarkson; Gemma Bryan; Susan Furness; Anne-Marie Glenny; Anne Littlewood; Martin G McCabe; Stefan Meyer; Tasneem Khalid
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

2.  Salivary passage of 5-fluorouracil during continuous infusion.

Authors:  G Milano; A Thyss; J Santini; M Frenay; E Francois; M Schneider; F Demard
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 3.  Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients.

Authors:  Siri Beier Jensen; Virginia Jarvis; Yehuda Zadik; Andrei Barasch; Anura Ariyawardana; Allan Hovan; Noam Yarom; Rajesh V Lalla; Joanne Bowen; Sharon Elad
Journal:  Support Care Cancer       Date:  2013-07-31       Impact factor: 3.603

Review 4.  Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management.

Authors:  Carla C P Verstappen; Jan J Heimans; Klaas Hoekman; Tjeerd J Postma
Journal:  Drugs       Date:  2003       Impact factor: 9.546

5.  Effect on liver tumor growth in rats of allopurinol and 5-fluorouracil in combination with hepatic artery ligation.

Authors:  G Carlsson; B Gustavsson; L Hafström
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.